Evidence map›Paper›PMID 36233798›Full record

ArticleJournal of clinical medicine2022

Visual Performance, Satisfaction, and Spectacle Independence after Implantation of a New Hydrophobic Trifocal Intraocular Lens.

Antonio Cano-Ortiz, Álvaro Sánchez-Ventosa, Timoteo González-Cruces, David Cerdán-Palacios, Vanesa Díaz-Mesa, Rubén Gallego-Ordóñez, Teresa Gálvez-Gómez, Jose A García Parrizas, Javier Zurera Baena, Alberto Villarrubia-Cuadrado

Registry-linked trialAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05776446 (Retrospective Study on the Clinical Behavior of the Asqelio™ Trifocal Diffractive Intraocular Lens With Follow-up at 3 Months), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05776446 completednot on this map

Retrospective Study on the Clinical Behavior of the Asqelio™ Trifocal Diffractive Intraocular Lens With Follow-up at 3 Months

TypeobservationalSponsorAST Products, Inc.Ran2022 to 2022Enrolled25ConditionsCataract
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Frontiers in medicine · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Antonio Cano-OrtizDepartment of Ophthalmology, Hospital La Arruzafa, 14012 Córdoba, Spain.ORCID 0000-0003-3587-7892
Álvaro Sánchez-VentosaDepartment of Ophthalmology, Hospital La Arruzafa, 14012 Córdoba, Spain.ORCID 0000-0001-5303-988X
Timoteo González-CrucesDepartment of Ophthalmology, Hospital La Arruzafa, 14012 Córdoba, Spain.ORCID 0000-0001-9594-1601
David Cerdán-PalaciosDepartment of Ophthalmology, Hospital La Arruzafa, 14012 Córdoba, Spain.
Vanesa Díaz-MesaDepartment of Ophthalmology, Hospital La Arruzafa, 14012 Córdoba, Spain.
Rubén Gallego-OrdóñezDepartment of Ophthalmology, Hospital La Arruzafa, 14012 Córdoba, Spain.
Teresa Gálvez-GómezDepartment of Ophthalmology, Hospital La Arruzafa, 14012 Córdoba, Spain.
Jose A García ParrizasDepartment of Ophthalmology, Hospital La Arruzafa, 14012 Córdoba, Spain.
Javier Zurera BaenaDepartment of Ophthalmology, Hospital La Arruzafa, 14012 Córdoba, Spain.
Alberto Villarrubia-CuadradoDepartment of Ophthalmology, Hospital La Arruzafa, 14012 Córdoba, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main objective was to evaluate distance, intermediate, and near vision in patients who have undergone cataract extraction with bilateral implantation of a new trifocal diffractive intraocular lens (IOL), along with patient-reported outcomes (PRO). A total of 50 eyes from 25 patients after Asqelio

Indexed as

spectacle independencetrifocal intraocular lensvisual questionnaire

Identifiers

PMID36233798
PMCPMC9573246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.